In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients - 06/11/18

This research was cofunded by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, NIHR Leicester Biomedical Research Centre, Asthma UK (08/11), the Medical Research Council (grant no. MR/J00345X/1), the Wellcome Trust (grant no. 098351/Z/12/Z), Wellcome Trust Senior Fellowship (grant no. WT082265 to C.E.B.), and AirPROM 7th EU Framework grant, and supported by the NIHR Cambridge Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care. |
|
Disclosure of potential conflict of interest: E. R. Chilvers' institution receives noncommercial grant support from GSK, MedImmune, and BMS to support work in his laboratory. C. E. Brightling reports grants from Wellcome, AirPROM, and the National Institute for Health Research during the conduct of the study; grants and personal fees from GlaxoSmithKline, AstraZeneca/Medimmune, Novartis, Chiesi, Boehringer-Ingelheim, and Roche/Genentech; personal fees from Vectura, Gossamer, Theravance, PreP, Gilead, Sanofi/Regeneron, Teva, and 4DPharma, outside the submitted work; and grants from Pfizer and Mologic. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 142 - N° 5
P. 1659 - novembre 2018 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?